Slide 1: 6 months ended 31 December 2004
TM 6 months ended 371 December, 2004
Slide 2: Outline
Outline Financial Highlights Interim December 31, 2004 : Strategy Moving Forward .
Slide 3: Financial Highlights Interim Dec 2004: Revenue
Financial Highlights Interim Dec 2004 REVENUE @ Record revenues of $19.2m for the half. @ Acquisition of the DWL business in Germany - contributed $2.4m in the current period. 8 Short term sales impact relating mainly to ressure on. xport sz
Slide 4: Financial Highlights Interim Dec: Profit
Financial Highlights Interim Dec 20 PROFIT @ High investment levels in R&D and product development (18% of revenues), as a reflection ofa strong sales outlook and product pipeline -Loss at the NPAT line of $0. 8m compares with last year’s $1.1m profit. : Short term results impacted by the acquisitio
Slide 5: Financial Highlights Interim Dec 2004: Cash and Growth
Financial Highlights Interim Dec 2004 CASH ® Positive operating-cash at $0.7m. Net cash down $1.7m as a result of debt repayment $1.4m and dividend payments of $0.7m. GROWTH -@ Europe business strengthened and i is now ready for execution of growth strategy similar to the USA with | the building : d
Slide 6: Financial Highlights: Cost Controls
Financial Highlights Interim Dec 2004 COST CONTROLS ® . Inventory at $7.7m (20% of revenue) compares to inventory at same time last it year of $7.5m or 22% of revenues. . @ Margins improve from 59% to 61% despite strong ote Australian Dollar. OPERA TING EFFICIENCIES
Slide 7: Achievements for the months
Achievements for the 6 months Acquisition of DWL in Singen, Germany. European base now established, positioning Europe for Japid growth outlook. ~ © Contributed $2. 4m revenue for the period from 1 ~ September, 2004. = + Key management secured by DWL business ~ founders. . = 24 other staff
Slide 8: Historical Sales Graph
Historical Sales Graph AU$m 25 20 “15 CIM!
Slide 9: Strong growth continues in USA
Strong growth continues in USA 2004 Europe Asia Australia Oy oof Asia 10% —
Slide 10: Slide 10
Slide 11: A Big Market to Grow In
A Big Market to Grow In High investment (18% of revenues) levels in R&D and product development continue, as a reflection of a strong sales outlook and product pipeline Estimated global market value =AUDh) 27 billion
Slide 12: Moving Forward: Technologies
Moving Forward : Technologies Curry 5.0 -Siesta802 ComperioDQ StimIl
Slide 13: Strategy Working
Strategy Working Building a global medical diagnostic company — 8 With Compumedics’ core strategic edge being Sleep Diagnostics and @ Leveraging this technology into related fields ; and Cardiology.
Slide 14: Moving Forward: Business
Moving Forward : Business » Revenues expected to be around the $38 to $42 million. region for year ended June 30, 2005. = Earnings after tax-expected to be between $1 million and $3 million-for- year ended June 30, 2005. « Revenue in the second half expected to be stronger over the _ first half in 2
Slide 15: Moving Forward: Business (cont.)
Moving Forward : BuSiness (ona « Europe positioned growth as infrastructure there is built in a similar way to that of the USA (organic growth and continued integration of DWL business). ~® The cost efficiency programs and lean processes have just commenced but are already being amplified for the ye
Slide 16: Recap / Way Forward
Recap / Way Forward Strong product pipelines and technology product leadership paves way for strong sales outlook in sleep, neurology and doppler blood flow. 7. 2. Positive cash position. - - Strong product pipeline and Medical innovation breakthroughs on - the horizon. 4. USA growth and accelerated